Host-microbial interactions in Wegener’s Granulomatosis: The role of ANCA and S. aureus persistence
Investigator: Robert D. Inman, M.D.
Location: University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
Timeline: September 1, 2002 – August 31, 2003 (extended to Spring 2004)
Abstract: There is compelling circumstantial evidence to implicate a role for infection in the pathogenesis of Wegener’s Granulomatosis (WG). Recently there has been confirmation of a higher nasal carriage of Staphylococcus aureus in WG patients. Yet it is not known whether this finding is a cause or an effect of the disease process. Secondly, there continues to be mounting evidence of the efficacy of antibiotic therapy for WG. It is unresolved however whether agents such as ulfonamide or trimethoprim function as antibiotics or by an alternative mechanism. Third, neutrophils represent the first line of defense against bacterial pathogens. The ANCA antibody response that is the hallmark of WG may influence host defenses against such infections in a fundamental way.
Specific Aims: The aims of the proposed project are to analyze the relationship between ANCA and clearance of pathogens. This will shed new light on the relationship between infection and autoantibody formation. This is one of the fundamental problems in all autoimmune disease, and the insights from this study will have important implications for other chronic inflammatory conditions, which may have an infectious trigger.
1. To define the impact of ANCA on the internalization and intracellular killing of S. aureus by neutrophils and by endothelial cells.
2. To examine the impact of ANCA on the parameters of innate immunity, particularly TLR2 and TLR4 signaling and activation of NFkB, as marker of gene transcription and cytokine production.
What this means for patients: There is compelling reason to resolve the possible role of infection in WG:
1. As has just been confirmed, WG patients have a higher prevalence of nasal carriage in S. aureus. The reason for this microbial persistence has not been resolved.
2. Antibiotics form an important part of the treatment regimen of WG, and it has been assumed that the primary mode of action of these agents is their antimicrobial effect.
3. Since the neutrophil functions as a first line of defense against pathogens such as S. aureus, it is important to resolve whether ANCA may be significantly impairing host defenses against infection by altering neutrophil function.
Vasculitis Foundation Research Program
- VF Grant Instructions and Application
- Research Policies and Award Process
- VF Funded Research
- Short-term cyclophosphamide therapy in a cohort of over 200 Patients
- Host-microbial interactions in Wegener’s Granulomatosis: The role of ANCA and S. aureus persistence
- The role of shear stress in neutrophil proteinase-3 expression and its importance in vascular injury sites in WG
- Analysis of NKG2D expression on CD28
- Identification of Novel Wegener’s Granulomatosis Susceptibility Genes
- Environmental Factors in the Pathogenesis of Wegener’s Granulomatosis
- Localized Wegener’s Granulomatosis: Epidemiological, clinical and histopathological characteristics
- Wegener’s Granulomatosis and Microscopic Polyarteritis Case Control Study in Western Montana
- Development of a Measure to Assess Patients’ Adherence to Vasculitis Treatment Regimens
- A Pilot Project towards Establishment of a US/Canadian Diagnostic Registry of Children with WG and Related Vasculitides
- Renal transplantation in WG: mortality, allograft outcomes, and incidence of malignancies from the United States
- Identification and characterization of immunodominant, conformational epitopes of anti-neutrophil cytoplasmic antibodies
- An Investigation of the Role of the Innate Immune Response in Kawasaki Disease
- ANCA Vasculitis: Autoimmune B Cell Dysregulation and its Clinical Impact
- Expression and activation of p38 MAPK isoforms in ANCA-associated renal vasculitis
- Gene Expression Profile of Temporal Arteritis in Giant Cell Arteritis
- Investigating the role of the novel Th17 cells in the pathogenesis of ANCA associated vasculitis...
- Vasculitic T Cells in Giant Cell Arteritis
- Current Research Studies with Open Enrollment

>

